Economic burden in patients (pt) with CLL/SLL (CLL) who received ≥ 2 prior lines of therapy (LOT), including a Bruton tyrosine kinase inhibitor (BTKi): A SEER-Medicare analysis. This is an ASCO ...
Dianthus achieved its NASDAQ listing last year via a merger with Magenta Therapeutics. The company is focused on development of a single drug candidate, DNTH-103, which targets the complement system, ...
MANASSAS, Va., Nov. 24, 2025 /PRNewswire/ -- Swelling, puffiness, and persistent fluid retention signal that the lymph system needs support. PureHealth Research addresses these widespread concerns ...
MANASSAS, Va., Jan. 5, 2026 /PRNewswire/ -- PureHealth Research announces their collection of supplements for nervous system support, designed for biohackers, executives, and wellness optimizers ...
Environmental change is reshaping food availability, nutrient quality, and health risks, exposing major gaps in how nutrition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback